Evidence map›Paper›PMID 18945902›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2008

Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation.

Brid Callaghan, Alison Haythornthwaite, Géza Berecki, Richard J Clark, David J Craik, David J Adams

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 161 citations in OpenAlex.

  1. GABAExperimental physiology · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Interleukin-1α links peripheral CaScientific reports · 2024
    Article
  6. Interleukin-1α links peripheral CabioRxiv : the preprint server for biology · 2024
    Article
  7. Review
  8. Cone snail species off the Brazilian coast and their venoms: a review and update.The journal of venomous animals and toxins including tropical diseases · 2023
    Review
  9. Marine drugs · 2022
    Review
  10. Article
  11. Article
  12. GABACurrent topics in behavioral neurosciences · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. MicroRNA-330 Directs Downregulation of the GABAJournal of molecular neuroscience : MN · 2020
    Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Brid CallaghanQueensland Brain Institute and School of Biomedical Sciences, and Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia.
Alison Haythornthwaite
Géza Berecki
Richard J Clark
David J Craik
David J Adams
Allen Institute for Brain Science · USUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

alpha-Conotoxins Vc1.1 and Rg1A are peptides from the venom of marine Conus snails that are currently in development as a treatment for neuropathic pain. Here we report that the alpha9alpha10 nicotinic acetylcholine receptor-selective conotoxins Vc1.1 and Rg1A potently and selectively inhibit high-voltage-activated (HVA) calcium channel currents in dissociated DRG neurons in a concentration-dependent manner. The post-translationally modified peptides vc1a and [P6O]Vc1.1 were inactive, as were all other alpha-conotoxins tested. Vc1.1 inhibited the omega-conotoxin-sensitive HVA currents in DRG neurons but not those recorded from Xenopus oocytes expressing Ca(V)2.2, Ca(V)2.1, Ca(V)2.3, or Ca(V)1.2 channels. Inhibition of HVA currents by Vc1.1 was not reversed by depolarizing prepulses but was abolished by pertussis toxin (PTX), intracellular GDPbetaS, or a selective inhibitor of pp60c-src tyrosine kinase. These data indicate that Vc1.1 does not interact with N-type calcium channels directly but inhibits them via a voltage-independent mechanism involving a PTX-sensitive, G-protein-coupled receptor. Preincubation with a variety of selective receptor antagonists demonstrated that only the GABA(B) receptor antagonists, [S-(R*,R*)][-3-[[1-(3,4-dichlorophenyl)ethyl]amino]-2-hydroxy propyl]([3,4]-cyclohexylmethyl) phosphinic acid hydrochloride (2S)-3[[(1S)-1-(3,4-dichlorophenyl)-ethyl]amino-2-hydroxypropyl](phenylmethyl) phosphinic acid and phaclofen, blocked the effect of Vc1.1 and Rg1A on Ca2+ channel currents. Together, the results identify Ca(V)2.2 as a target of Vc1.1 and Rg1A, potentially mediating their analgesic actions. We propose a novel mechanism by which alpha-conotoxins Vc1.1 and Rg1A modulate native N-type (Ca(V)2.2) Ca2+ channel currents, namely acting as agonists via G-protein-coupled GABA(B) receptors.

Indexed as

AnalgesicsAnimalsAnimals, NewbornBaclofenBariumCalcium Channel BlockersCalcium Channels, N-TypeCells, CulturedConotoxinsDose-Response Relationship, RadiationElectric StimulationGABA AntagonistsGanglia, SpinalMembrane Potentialsomega-ConotoxinsPatch-Clamp Techniquesalpha-conotoxin Vc1.1AnalgesicsBaclofenBariumCalcium Channel BlockersCalcium Channels, N-TypeCGP 55845Aconotoxin alpha-RgIA, Conus regiusConotoxinsGABA Antagonistsomega-ConotoxinsPertussis ToxinphaclofenPhosphinic AcidsPropanolaminesReceptors, GABA

Identifiers

PMID18945902
PMCPMC6671365
OpenAlexW1964673525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.